Man recovers after rare brain disorder misdiagnosed as Parkinson's disease
Local 12 speaks with patient, UC expert about importance of second opinions
Local 12 spoke with patient Rod Fussinger, his wife Claire, and UC's Joseph LaPorta about Rod's recovery from anti-IgLON5, a form of encephalopathy where antibodies attack the brain, that was initially misdiagnosed as Parkinson's disease.
Rod slept for days at a time, required a feeding tube and lost memory of significant events, such as his son's month-long visit. The family considered hospice care, but first sought a second opinion with LaPorta, DO, a physician researcher at the UC Gardner Neuroscience Institute.
"When I met Rod, it was actually in the hospital when he was in an almost comatose state, and that was less than a year from back when he was normal, and that's not how Parkinson's, Alzheimer's or its cousins progress," said LaPorta, assistant professor in the Department of Neurology and Rehabilitation Medicine in UC's College of Medicine.
Rod was treated with chemotherapy to eliminate the attacking antibodies. Within a year, he was alert and active.
"I had heard from his family he was doing better, but he stood up out of the chair and shook my hand, and this is a guy who wouldn't even interact with me, open his eyes," said LaPorta.
Rod advised anyone in his situation to seek second opinions and a medical team that will keep looking for answers.
"Yeah, I think they need to find somebody that will keep digging until they're sure because the different diseases are similar enough that if somebody is just busy wanting to get on to the next patient, it wouldn't be that hard for them to have a misdiagnosis, really," he said.
Watch or read the Local 12 story.
Featured photo at top of Joseph LaPorta. Photo/UC Health.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.